Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Jilin Province Innovative Pharmaceutical Public Service Platform is a specialized technical support organization located in Changchun, China, dedicated to fostering the regional life sciences industry. It provides a wide range of services including drug discovery, lead optimization, pharmacological evaluation, and safety testing for both chemical drugs and traditional Chinese medicines. By bridging the gap between academic research and industrial application, the platform offers shared laboratory facilities and pilot production capabilities to local biotech firms. It operates under the guidance of provincial science and technology authorities to streamline the drug development process from pre-clinical research to clinical trials. The platform integrates resources from major institutions like Jilin University and the Chinese Academy of Sciences to provide high-end analytical and R&D support. Its mission is to reduce the cost of innovation for small and medium-sized pharmaceutical enterprises in Northeast China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Province Innovative Pharmaceutical Public Service Platform.